Tempest Market Capitalization from 2010 to 2024

TPST Stock  USD 0.92  0.01  1.10%   
Tempest Therapeutics Market Cap yearly trend continues to be comparatively stable with very little volatility. Market Cap is likely to outpace its year average in 2024.
Check Tempest Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tempest Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 361.9 K, Interest Expense of 1.5 M or Selling General Administrative of 15.4 M, as well as many indicators such as Price To Sales Ratio of 1.36, Dividend Yield of 0.0 or PTB Ratio of 3.14. Tempest financial statements analysis is a perfect complement when working with Tempest Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tempest Therapeutics Correlation against competitors.
For more information on how to buy Tempest Stock please use our How to Invest in Tempest Therapeutics guide.

Latest Tempest Therapeutics' Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Tempest Therapeutics over the last few years. It is Tempest Therapeutics' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tempest Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 39.94 M10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Tempest Market Capitalization Regression Statistics

Arithmetic Mean134,863,324
Geometric Mean64,900,447
Coefficient Of Variation83.78
Mean Deviation103,804,333
Median92,383,360
Standard Deviation112,994,504
Sample Variance12767.8T
Range264.3M
R-Value(0.81)
Mean Square Error4683.2T
R-Squared0.66
Significance0.0002
Slope(20,517,174)
Total Sum of Squares178748.6T

Tempest Market Capitalization History

202479.8 M
202367.8 M
202213.3 M
202020 M
201892.4 M
2017368 K
201649.2 M

About Tempest Therapeutics Financial Statements

Tempest Therapeutics shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Tempest Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Tempest Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tempest Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc. Tempest Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Tempest Stock Analysis

When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.